Cálculo
Ratio de margen de beneficio neto | = | 100 | × | Ingresos netos (pérdidas) atribuibles a los accionistas de Illumina1 | ÷ | Ingresos1 | |
---|---|---|---|---|---|---|---|
31 dic. 2020 | 20.25% | = | 100 | × | 656) | ÷ | 3,239) |
29 dic. 2019 | 28.28% | = | 100 | × | 1,002) | ÷ | 3,543) |
30 dic. 2018 | 24.78% | = | 100 | × | 826) | ÷ | 3,333) |
31 dic. 2017 | 26.38% | = | 100 | × | 726) | ÷ | 2,752) |
1 ene. 2017 | 19.29% | = | 100 | × | 463) | ÷ | 2,398) |
3 ene. 2016 | 20.79% | = | 100 | × | 462) | ÷ | 2,220) |
28 dic. 2014 | 18.98% | = | 100 | × | 353) | ÷ | 1,861) |
29 dic. 2013 | 8.82% | = | 100 | × | 125) | ÷ | 1,421) |
30 dic. 2012 | 13.17% | = | 100 | × | 151) | ÷ | 1,149) |
1 ene. 2012 | 8.21% | = | 100 | × | 87) | ÷ | 1,056) |
2 ene. 2011 | 13.83% | = | 100 | × | 125) | ÷ | 903) |
3 ene. 2010 | 10.85% | = | 100 | × | 72) | ÷ | 666) |
28 dic. 2008 | 8.81% | = | 100 | × | 50) | ÷ | 573) |
30 dic. 2007 | -75.89% | = | 100 | × | (278) | ÷ | 367) |
31 dic. 2006 | 21.65% | = | 100 | × | 40) | ÷ | 185) |
1 ene. 2006 | -28.40% | = | 100 | × | (21) | ÷ | 74) |
Basado en los informes: 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-29), 10-K (Fecha del informe: 2018-12-30), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2017-01-01), 10-K (Fecha del informe: 2016-01-03), 10-K (Fecha del informe: 2014-12-28), 10-K (Fecha del informe: 2013-12-29), 10-K (Fecha del informe: 2012-12-30), 10-K (Fecha del informe: 2012-01-01), 10-K (Fecha del informe: 2011-01-02), 10-K (Fecha del informe: 2010-01-03), 10-K (Fecha del informe: 2008-12-28), 10-K (Fecha del informe: 2007-12-30), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2006-01-01).
1 US$ en millones
Comparación con la competencia
Illumina Inc., ratio de margen de beneficio neto, tendencias a largo plazo, comparación con los competidores
Illumina Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
31 dic. 2020 | 20.25% | 10.08% | 29.97% | -21.20% | 25.24% | 0.51% | 17.82% | 14.72% | 22.95% | 41.35% | 19.79% | 43.70% |
29 dic. 2019 | 28.28% | 23.69% | 35.32% | 13.15% | 37.27% | 24.35% | 18.42% | 21.01% | 31.45% | 26.91% | 14.47% | 28.27% |
30 dic. 2018 | 24.78% | 17.36% | 37.25% | 21.81% | 13.16% | 25.16% | 18.75% | 14.71% | 20.79% | 36.42% | 12.06% | 68.80% |
31 dic. 2017 | 26.38% | 18.82% | 9.08% | 4.85% | -0.89% | 18.03% | 1.70% | 5.97% | 40.55% | 20.41% | 10.64% | 10.59% |
1 ene. 2017 | 19.29% | 23.22% | 35.27% | 22.94% | 12.90% | 45.07% | 23.01% | 9.85% | 13.66% | 18.42% | 11.06% | -6.58% |
3 ene. 2016 | 20.79% | 22.50% | 33.13% | 9.45% | 12.07% | 56.32% | 21.99% | 11.25% | 14.25% | 15.50% | 11.64% | -53.89% |
28 dic. 2014 | 18.98% | 8.89% | 26.69% | 12.62% | 12.19% | 49.44% | 21.96% | 28.22% | 18.42% | 12.34% | 11.22% | -127.25% |
29 dic. 2013 | 8.82% | 21.97% | 27.93% | 15.64% | 20.27% | 28.46% | 19.40% | 10.00% | 42.65% | 20.16% | 9.73% | -36.72% |
30 dic. 2012 | 13.17% | 28.70% | 26.11% | 11.12% | 18.09% | 27.57% | 16.14% | 13.05% | 24.70% | 54.43% | 9.42% | -7.01% |
1 ene. 2012 | 8.21% | — | 24.08% | 17.46% | 17.90% | 34.60% | 14.87% | 13.05% | 14.84% | -49.74% | 11.34% | 2.10% |
2 ene. 2011 | 13.83% | — | 31.56% | 15.92% | 21.97% | 39.26% | 21.65% | 1.87% | 12.18% | -22.76% | 9.60% | -526.35% |
3 ene. 2010 | 10.85% | — | 32.09% | 56.42% | 19.82% | 40.74% | 19.82% | 47.04% | 17.27% | -17.88% | 8.41% | -630.27% |
28 dic. 2008 | 8.81% | — | 28.57% | 25.47% | -10.17% | 39.55% | 20.31% | 32.74% | 16.78% | -34.69% | 9.47% | -262.02% |
30 dic. 2007 | -75.89% | — | 22.12% | 11.19% | 15.85% | 43.27% | 17.31% | 13.54% | 16.82% | -84.46% | 7.81% | -196.61% |
31 dic. 2006 | 21.65% | — | 21.29% | 8.85% | 16.97% | -45.98% | 20.73% | 19.59% | 39.98% | -161.30% | 4.46% | -95.63% |
1 ene. 2006 | -28.40% | — | 30.56% | 15.62% | 13.52% | 44.99% | 20.61% | 21.04% | 15.76% | -144.19% | 8.48% | -126.43% |
Basado en los informes: 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-29), 10-K (Fecha del informe: 2018-12-30), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2017-01-01), 10-K (Fecha del informe: 2016-01-03), 10-K (Fecha del informe: 2014-12-28), 10-K (Fecha del informe: 2013-12-29), 10-K (Fecha del informe: 2012-12-30), 10-K (Fecha del informe: 2012-01-01), 10-K (Fecha del informe: 2011-01-02), 10-K (Fecha del informe: 2010-01-03), 10-K (Fecha del informe: 2008-12-28), 10-K (Fecha del informe: 2007-12-30), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2006-01-01).
Comparación con el sector industrial: Productos farmacéuticos, biotecnología y ciencias de la vida
Illumina Inc., ratio de margen de beneficio neto, tendencias a largo plazo, comparación con el sector industrial: productos farmacéuticos, biotecnología y ciencias de la vida
Illumina Inc. | Productos farmacéuticos, biotecnología y ciencias de la vida | |
---|---|---|
31 dic. 2020 | 20.25% | 13.96% |
29 dic. 2019 | 28.28% | 23.55% |
30 dic. 2018 | 24.78% | 20.21% |
31 dic. 2017 | 26.38% | 13.03% |
1 ene. 2017 | 19.29% | 21.09% |
3 ene. 2016 | 20.79% | 21.51% |
28 dic. 2014 | 18.98% | 21.81% |
29 dic. 2013 | 8.82% | 22.55% |
30 dic. 2012 | 13.17% | 18.89% |
1 ene. 2012 | 8.21% | 15.83% |
2 ene. 2011 | 13.83% | 15.25% |
3 ene. 2010 | 10.85% | 26.55% |
28 dic. 2008 | 8.81% | 18.64% |
30 dic. 2007 | -75.89% | 16.10% |
31 dic. 2006 | 21.65% | 22.80% |
1 ene. 2006 | -28.40% | 18.65% |
Basado en los informes: 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-29), 10-K (Fecha del informe: 2018-12-30), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2017-01-01), 10-K (Fecha del informe: 2016-01-03), 10-K (Fecha del informe: 2014-12-28), 10-K (Fecha del informe: 2013-12-29), 10-K (Fecha del informe: 2012-12-30), 10-K (Fecha del informe: 2012-01-01), 10-K (Fecha del informe: 2011-01-02), 10-K (Fecha del informe: 2010-01-03), 10-K (Fecha del informe: 2008-12-28), 10-K (Fecha del informe: 2007-12-30), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2006-01-01).
Comparación con la industria: Atención médica
Illumina Inc., ratio de margen de beneficio neto, tendencias a largo plazo, comparación con la industria: atención médica
Illumina Inc. | Atención médica | |
---|---|---|
31 dic. 2020 | 20.25% | 7.86% |
29 dic. 2019 | 28.28% | 10.19% |
30 dic. 2018 | 24.78% | 9.34% |
31 dic. 2017 | 26.38% | 7.76% |
1 ene. 2017 | 19.29% | 9.88% |
3 ene. 2016 | 20.79% | 10.90% |
28 dic. 2014 | 18.98% | 11.28% |
29 dic. 2013 | 8.82% | 11.91% |
30 dic. 2012 | 13.17% | 11.15% |
1 ene. 2012 | 8.21% | 10.00% |
2 ene. 2011 | 13.83% | 9.96% |
3 ene. 2010 | 10.85% | 14.21% |
28 dic. 2008 | 8.81% | 10.53% |
30 dic. 2007 | -75.89% | 10.49% |
31 dic. 2006 | 21.65% | 13.15% |
1 ene. 2006 | -28.40% | 12.83% |
Basado en los informes: 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-29), 10-K (Fecha del informe: 2018-12-30), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2017-01-01), 10-K (Fecha del informe: 2016-01-03), 10-K (Fecha del informe: 2014-12-28), 10-K (Fecha del informe: 2013-12-29), 10-K (Fecha del informe: 2012-12-30), 10-K (Fecha del informe: 2012-01-01), 10-K (Fecha del informe: 2011-01-02), 10-K (Fecha del informe: 2010-01-03), 10-K (Fecha del informe: 2008-12-28), 10-K (Fecha del informe: 2007-12-30), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2006-01-01).